Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response
- 1 March 2019
- Vol. 37 (14) , 1945-1953
Abstract
No abstract availableKeywords
Funding Information
- USDA-NIFA (IND020164H)
This publication has 58 references indexed in Scilit:
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitroImmunology Letters, 2012
- Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA virusesCytokine & Growth Factor Reviews, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccinesProceedings of the National Academy of Sciences, 2008
- Molecular and cellular signatures of human vaccine adjuvantsProceedings of the National Academy of Sciences, 2008
- The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activityEuropean Journal of Immunology, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Formulation of vaccines containing CpG oligonucleotides and alumJournal of Immunological Methods, 2007
- Toll-like receptor signallingNature Reviews Immunology, 2004